BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 28599998)

  • 1. [PET scan and NMR spectroscopy for the differential diagnosis between brain radiation necrosis and tumour recurrence after stereotactic irradiation of brain metastases: Place in the decision tree].
    Menoux I; Noël G; Namer I; Antoni D
    Cancer Radiother; 2017 Aug; 21(5):389-397. PubMed ID: 28599998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Imaging methods used in the differential diagnosis between brain tumour relapse and radiation necrosis after stereotactic radiosurgery of brain metastases: Literature review].
    Menoux I; Armspach JP; Noël G; Antoni D
    Cancer Radiother; 2016 Dec; 20(8):837-845. PubMed ID: 28270324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain metastases after stereotactic radiosurgery using the Leksell gamma knife: can FDG PET help to differentiate radionecrosis from tumour progression?
    Belohlávek O; Simonová G; Kantorová I; Novotný J; Liscák R
    Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):96-100. PubMed ID: 12483415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery: is a differential diagnosis possible?
    Tsuyuguchi N; Sunada I; Iwai Y; Yamanaka K; Tanaka K; Takami T; Otsuka Y; Sakamoto S; Ohata K; Goto T; Hara M
    J Neurosurg; 2003 May; 98(5):1056-64. PubMed ID: 12744366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reliability of Magnetic Resonance Spectroscopy and Positron Emission Tomography Computed Tomography in Differentiating Metastatic Brain Tumor Recurrence from Radiation Necrosis.
    Travers S; Joshi K; Miller DC; Singh A; Nada A; Biedermann G; Cousins JP; Litofsky NS
    World Neurosurg; 2021 Jul; 151():e1059-e1068. PubMed ID: 34052453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic radiotherapy following surgery for brain metastasis: Predictive factors for local control and radionecrosis.
    Doré M; Martin S; Delpon G; Clément K; Campion L; Thillays F
    Cancer Radiother; 2017 Feb; 21(1):4-9. PubMed ID: 27955888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methionine positron emission tomography for differentiation of recurrent brain tumor and radiation necrosis after stereotactic radiosurgery--in malignant glioma.
    Tsuyuguchi N; Takami T; Sunada I; Iwai Y; Yamanaka K; Tanaka K; Nishikawa M; Ohata K; Torii K; Morino M; Nishio A; Hara M
    Ann Nucl Med; 2004 Jun; 18(4):291-6. PubMed ID: 15359921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Differential diagnosis of local tumor recurrence or radionecrosis after stereotactic radiosurgery for treatment of brain metastasis].
    Patsouris A; Augereau P; Tanguy JY; Morel O; Menei P; Rousseau A; Paumier A
    Cancer Radiother; 2014 Mar; 18(2):142-6. PubMed ID: 24433952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of
    Garcia JR; Cozar M; Baquero M; Fernández Barrionuevo JM; Jaramillo A; Rubio J; Maida G; Soler M; Riera E
    Rev Esp Med Nucl Imagen Mol; 2017; 36(2):85-90. PubMed ID: 27503425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of (11)C-methionine, (11)C-choline, and (18)F-fluorodeoxyglucose-PET for distinguishing glioma recurrence from radiation necrosis.
    Takenaka S; Asano Y; Shinoda J; Nomura Y; Yonezawa S; Miwa K; Yano H; Iwama T
    Neurol Med Chir (Tokyo); 2014; 54(4):280-9. PubMed ID: 24305028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential for differentiation of glioma recurrence from radionecrosis using integrated
    Sogani SK; Jena A; Taneja S; Gambhir A; Mishra AK; D'Souza MM; Verma SM; Hazari PP; Negi P; Jadhav GK
    Neurol India; 2017; 65(2):293-301. PubMed ID: 28290392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Risk of radionecrosis after hypofractionated stereotactic radiotherapy targeting the postoperative resection cavity of brain metastases].
    Keller A; Doré M; Antoni D; Menoux I; Thillays F; Clavier JB; Delpon G; Jarnet D; Bourrier C; Lefebvre F; Chibbaro S; Darié I; Proust F; Noël G
    Cancer Radiother; 2017 Aug; 21(5):377-388. PubMed ID: 28551018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of O-(2-(18)F-fluoroethyl)-L-tyrosine PET for differentiation of local recurrent brain metastasis from radiation necrosis.
    Galldiks N; Stoffels G; Filss CP; Piroth MD; Sabel M; Ruge MI; Herzog H; Shah NJ; Fink GR; Coenen HH; Langen KJ
    J Nucl Med; 2012 Sep; 53(9):1367-74. PubMed ID: 22872742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What effective technique to differentiate radiation brain necrosis from a tumor progression in patients treated with radiation: A monocentric retrospective study combining the MRI TRAMs technique and the (
    Lakehayli Z; Phlips P; Margoum A; Saoudi A; Hmaid L; Nejjar I; Oueslati H; Bourgois N; Dao S; Belkhir F
    Cancer Radiother; 2023 Jun; 27(4):273-280. PubMed ID: 37080856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic O-(2-18F-fluoroethyl)-L-tyrosine positron emission tomography differentiates brain metastasis recurrence from radiation injury after radiotherapy.
    Ceccon G; Lohmann P; Stoffels G; Judov N; Filss CP; Rapp M; Bauer E; Hamisch C; Ruge MI; Kocher M; Kuchelmeister K; Sellhaus B; Sabel M; Fink GR; Shah NJ; Langen KJ; Galldiks N
    Neuro Oncol; 2017 Feb; 19(2):281-288. PubMed ID: 27471107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of intracranial radiation necrosis following postoperative radiation therapy for sinonasal malignancies.
    Ahmad S; Le CH; Chiu AG; Chang EH
    Laryngoscope; 2016 Nov; 126(11):2445-2450. PubMed ID: 27296477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of MRI, F-18 FDG, and 11C-choline PET/CT for their potentials in differentiating brain tumor recurrence from brain tumor necrosis following radiotherapy.
    Tan H; Chen L; Guan Y; Lin X
    Clin Nucl Med; 2011 Nov; 36(11):978-81. PubMed ID: 21975383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiating radiation necrosis from tumor progression in brain metastases treated with stereotactic radiotherapy: utility of intravoxel incoherent motion perfusion MRI and correlation with histopathology.
    Detsky JS; Keith J; Conklin J; Symons S; Myrehaug S; Sahgal A; Heyn CC; Soliman H
    J Neurooncol; 2017 Sep; 134(2):433-441. PubMed ID: 28674974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Brain radiation necrosis after stereotactic radiotherapy of the resection cavity for intracranial metastases: analysis of the literature from four cases].
    Doré M; Lefebvre L; Delpon G; Thillays F
    Cancer Radiother; 2015 Apr; 19(2):111-9. PubMed ID: 25573799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined FET PET/MRI radiomics differentiates radiation injury from recurrent brain metastasis.
    Lohmann P; Kocher M; Ceccon G; Bauer EK; Stoffels G; Viswanathan S; Ruge MI; Neumaier B; Shah NJ; Fink GR; Langen KJ; Galldiks N
    Neuroimage Clin; 2018; 20():537-542. PubMed ID: 30175040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.